Related Experiment Video
Updated: May 15, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Increased iodine uptake in the Nabothian cyst
Shuai Liu1, Min Zhang, Yumin Qu
1Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Clinical Nuclear Medicine
|January 22, 2013
Summary
Papillary thyroid cancer patients may show increased iodine uptake in the cervix on post-therapy scans. This finding, often mistaken for recurrence, can be caused by benign cervical Nabothian cysts.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Papillary thyroid cancer (PTC) is the most common type of thyroid malignancy.
- Radioiodine (131I) therapy is a standard treatment for residual or metastatic PTC.
- Post-therapy whole-body scans (RxWBS) are used to assess treatment effectiveness and detect recurrence.
Observation:
- A 31-year-old female patient with a history of PTC underwent radioiodine therapy.
- A post-therapy SPECT scan revealed unexpected focal iodine accumulation in the cervix.
- This finding prompted further investigation to determine its origin.
Findings:
- Ultrasound examination identified the cervical iodine uptake as a Nabothian cyst.
- Nabothian cysts are benign cervical inclusion cysts and do not represent thyroid cancer recurrence.
- This case highlights a potential imaging pitfall in post-treatment PTC surveillance.
Implications:
- Benign cervical structures like Nabothian cysts can mimic metastatic disease on radioiodine scans.
- Careful correlation with anatomical imaging (e.g., ultrasound) is crucial for accurate interpretation.
- Understanding these benign mimics can prevent unnecessary patient anxiety and further invasive investigations.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
